BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32430337)

  • 1. DNA Methylation-Derived Immune Cell Profiles, CpG Markers of Inflammation, and Pancreatic Cancer Risk.
    Michaud DS; Ruan M; Koestler DC; Alonso L; Molina-Montes E; Pei D; Marsit CJ; De Vivo I; Malats N; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2020 Aug; 29(8):1577-1585. PubMed ID: 32430337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenome-Wide Association Study Using Prediagnostic Bloods Identifies New Genomic Regions Associated With Pancreatic Cancer Risk.
    Michaud DS; Ruan M; Koestler DC; Pei D; Marsit CJ; De Vivo I; Kelsey KT
    JNCI Cancer Spectr; 2020 Oct; 4(5):pkaa041. PubMed ID: 33134824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New DNA Methylation Markers for Pancreatic Cancer: Discovery, Tissue Validation, and Pilot Testing in Pancreatic Juice.
    Kisiel JB; Raimondo M; Taylor WR; Yab TC; Mahoney DW; Sun Z; Middha S; Baheti S; Zou H; Smyrk TC; Boardman LA; Petersen GM; Ahlquist DA
    Clin Cancer Res; 2015 Oct; 21(19):4473-81. PubMed ID: 26023084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
    Mishra NK; Guda C
    Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk.
    Zhu J; Yang Y; Kisiel JB; Mahoney DW; Michaud DS; Guo X; Taylor WR; Shu XO; Shu X; Liu D; Li B; Tao R; Cai Q; Zheng W; Long J; Wu L
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2079-2087. PubMed ID: 34497089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-Wide Measures of Peripheral Blood Dna Methylation and Prostate Cancer Risk in a Prospective Nested Case-Control Study.
    FitzGerald LM; Naeem H; Makalic E; Schmidt DF; Dowty JG; Joo JE; Jung CH; Bassett JK; Dugue PA; Chung J; Lonie A; Milne RL; Wong EM; Hopper JL; English DR; Severi G; Baglietto L; Pedersen J; Giles GG; Southey MC
    Prostate; 2017 Apr; 77(5):471-478. PubMed ID: 28116812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide profiling of methylated promoters in pancreatic adenocarcinoma.
    Omura N; Li CP; Li A; Hong SM; Walter K; Jimeno A; Hidalgo M; Goggins M
    Cancer Biol Ther; 2008 Jul; 7(7):1146-56. PubMed ID: 18535405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome.
    Fridley BL; Armasu SM; Cicek MS; Larson MC; Wang C; Winham SJ; Kalli KR; Koestler DC; Rider DN; Shridhar V; Olson JE; Cunningham JM; Goode EL
    BMC Med Genomics; 2014 Apr; 7():21. PubMed ID: 24774302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediagnostic White Blood Cell DNA Methylation and Risk of Breast Cancer in the Prostate Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort.
    Sturgeon SR; Sela DA; Browne EP; Einson J; Rani A; Halabi M; Kania T; Keezer A; Balasubramanian R; Ziegler RG; Schairer C; Kelsey KT; Arcaro KF
    Cancer Epidemiol Biomarkers Prev; 2021 Aug; 30(8):1575-1581. PubMed ID: 34108140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter targeted bisulfite sequencing reveals DNA methylation profiles associated with low sperm motility in asthenozoospermia.
    Du Y; Li M; Chen J; Duan Y; Wang X; Qiu Y; Cai Z; Gui Y; Jiang H
    Hum Reprod; 2016 Jan; 31(1):24-33. PubMed ID: 26628640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative DNA methylome analysis of pan-cancer biomarkers in cancer discordant monozygotic twin-pairs.
    Roos L; van Dongen J; Bell CG; Burri A; Deloukas P; Boomsma DI; Spector TD; Bell JT
    Clin Epigenetics; 2016; 8():7. PubMed ID: 26798410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
    Shinjo K; Hara K; Nagae G; Umeda T; Katsushima K; Suzuki M; Murofushi Y; Umezu Y; Takeuchi I; Takahashi S; Okuno Y; Matsuo K; Ito H; Tajima S; Aburatani H; Yamao K; Kondo Y
    PLoS One; 2020; 15(6):e0233782. PubMed ID: 32520974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-derived inflammatory measures and lung cancer risk and survival.
    Zhao N; Ruan M; Koestler DC; Lu J; Salas LA; Kelsey KT; Platz EA; Michaud DS
    Clin Epigenetics; 2021 Dec; 13(1):222. PubMed ID: 34915912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte DNA methylation signature differentiates pancreatic cancer patients from healthy controls.
    Pedersen KS; Bamlet WR; Oberg AL; de Andrade M; Matsumoto ME; Tang H; Thibodeau SN; Petersen GM; Wang L
    PLoS One; 2011 Mar; 6(3):e18223. PubMed ID: 21455317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Curia MC; Fantini F; Lattanzio R; Tavano F; Di Mola F; Piantelli M; Battista P; Di Sebastiano P; Cama A
    BMC Cancer; 2019 May; 19(1):452. PubMed ID: 31088413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of inflammatory markers and DNA methylation, an analysis of repeated samples from a population based cohort.
    Myte R; Sundkvist A; Van Guelpen B; Harlid S
    Epigenetics; 2019 Jul; 14(7):649-659. PubMed ID: 31033411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
    Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
    Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary study analyzing the methylated genes in the plasma of patients with pancreatic cancer.
    Park JW; Baek IH; Kim YT
    Scand J Surg; 2012; 101(1):38-44. PubMed ID: 22414467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA Methylation in Peripheral Blood: Providing Novel Biomarkers of Exposure and Immunity to Examine Cancer Risk.
    Michaud DS; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2176-2178. PubMed ID: 34862269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel methylation signature predicts inferior outcome of patients with PDAC.
    Gu M; Sun J; Zhang S; Chen J; Wang G; Ju S; Wang X
    Aging (Albany NY); 2021 Jan; 13(2):2851-2863. PubMed ID: 33550277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.